BNF:

Not listed

Status:

Red

Decision Date:

May 2014

Comments

RED:^1,2,3,8 :NICE TA748 - Mexiletine for treating the symptoms of myotonia in non-dystrophic myotonic disorders. (Decision date - Feb 2022)

Red Drug Classifications

• 1: Requiring specialist assessment to enable patient selection, initiation and ongoing treating
• 2: Requiring long term on-going monitoring of efficacy by a specialist and not suitable for shared care
• 3: Requiring long term on-going monitoring of toxicity by a specialist (either because of difficulty in recognising side effects or high cost of investigations to identify toxicity)
• 8. NHS England commissioned – to be used in line with NHSE commissioning intentions

search again